The FDA recently authorized the First To Know Syphilis Test, the first at-home OTC diagnostic tool to help combat skyrocketing syphilis case counts in the U.S.
Syphilis is a sexually transmitted infection characterized by sores and can lead to serious health issues if left untreated, including heart and brain damage.
The home-use test from NOWDiagnostics boasts over 93% accuracy for positive results and over 99% for negative, but confirmation is needed from a healthcare professional.
The rise in syphilis cases, from 115,000 to over 207,000 between 2018 and 2022, highlights the urgent need for accessible diagnostics like this new test.
Collection
[
|
...
]